Aggressive behavior of nonmelanotic skin cancers in solid organ transplant recipients

Transplantation

Volumn 90, Issue 6, 2010, Pages 683-687

  Lott, David G ^a   Manz, Ryan ^a   Koch, Carl ^b   Lorenz, Robert R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

Author keywords

Basal cell cancer; Immunosuppression; Skin cancer; Squamous cell cancer; Transplant

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; SKIN CANCER; SQUAMOUS CELL CARCINOMA; ADOLESCENT; AGE; AGGRESSION; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CHILD; INTENSIVE CARE UNIT; MIDDLE AGED; PSYCHOLOGY; SKIN NEOPLASMS; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGGRESSION; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CHILD; HUMANS; INTENSIVE CARE UNITS; MIDDLE AGED; ORGAN TRANSPLANTATION; SKIN NEOPLASMS;

EID: 77957262713     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181ec7228     Document Type: Article

References (27)

1. EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV. 6.2. Cancer risk after renal transplantation. Skin cancers: Prevention and treatment. Nephrol Dial Transplant 2002; 17(suppl 4): 31.
2. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348: 1681.
3. Penn I. Cancers in renal transplant recipients. Adv Renal Transplant Ther 2000; 7: 147.
4. Barr BB, Benton EC, McLaren K, et al. Human papilloma virus infection and skin cancer in renal allograft recipients. Lancet 1988; 1: 124.
5. Adamson R, Obispo E, Dychter S, et al. High incidence and clinical course of aggressive skin cancer in heart transplant patients: A single-center study. Transplant Proc 1998; 30: 1124.
6. Penn I, HammondW,Brettschneider L, et al. Malignant lymphomas in transplantation patients. Transplant Proc 1969; 1: 106.
7. Moloney FJ, ComberH,O'LorcainP,etal.Apopulation-based study of skin cancer incidence and prevalence in renal transplant recipients.Br J Dermatol 2006; 154: 498.
8. Otley CC, Coldiron BM, Stasko T, et al. Decreased skin cancer after cessation of therapy with transplant-associated immunosuppressants. Arch Dermatol 2001; 137: 459.
9. Lewis KG, Weinstock MA. Nonmelanoma skin cancer mortality (1988-2000). The Rhode Island follow-back study. Arch Dermatol 2004; 140: 837.
10. Sheil AG, Disney AP, Mathew TH, et al. De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation. Transplant Proc 1993; 25: 1383.
11. Buell JF, Hanaway MJ, Thomas M, et al. Skin cancer following transplantation: The Israel Penn International Transplant Tumor Registry experience. Transplant Proc 2005; 37: 962.
12. Ramsay HM, Fryer AA, Reece SM, et al. Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients. Am J Kidney Dis 2000; 36: 167.
13. Cooper JZ, Brown MD. Special concern about squamous cell carcinoma of the scalp in organ transplant recipients. Arch Dermatol 2006; 142: 755.
14. Smith KJ, Hamza S, Skelton H. Histologic features in primary cutaneous squamous cell carcinomas in immunocompromised patients focusing on organ transplant patients. Dermatol Surg 2004; 30(4 pt 2): 634.
15. Traywick C, O'Reilly FM. Management of skin cancer in solid organ transplant recipients. Dermatol Ther 2005; 18: 12.
16. Lennard L, Thomas S, Harrington CI, et al. Skin cancer in renal transplant recipients is associated with increased concentrations of 6-thioguanine nu-cleotide in red blood cells. Br J Dermatol 1985; 113: 723.
17. Harwood CA, Proby CM, McGregor JM, et al. Clinicopathologic features ofskin cancer inorgan transplant recipients:Aretrospective case-control series. J Am Acad Dermatol 2006; 54: 290.
18. Servilla KS, Burnham DK, Daynes RA. Ability of cyclosporine to promote the growth of transplanted ultraviolet radiation-induced tumors in mice. Transplantation 1987; 44: 291.
19. Boyle J, MacKie RM, Briggs JD, et al. Cancer, warts, and sunshine in renal transplant patients. A case-control study. Lancet 1984; 1: 702.
20. Moore DE, Sik RH, Bilski P, et al. Photochemical sensitization by aza-thioprine and its metabolites. Part 3. A direct EPR and spin-trapping study of light-induced free radicals from 6-mercaptopurine and its oxidation products. Photochem Photobiol 1994; 60: 574.
21. Xu J, Lamouille S, Derynck R. TGF-beta-induced epithelial to mesen-chymal transition. Cell Res 2009; 19: 156.
22. Hojo M, Morimoto T, Maluccio M, et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 1999; 397: 530.
23. Forslund O, Ly H, Reid C, et al. A broad spectrum of human papillo-mavirus types is present in the skin of Australian patients with non-melanoma skin cancers and solar keratosis.Br JDermatol2003; 149: 64.
24. Karagas MR, Nelson HH, Sehr P, et al. Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst 2006; 98: 389.
25. Harwood CA, Surentheran T, McGregor JM, et al. Human papilloma-virus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 2000; 61: 289.
26. Shamanin V, zur Hausen H, Lavergne D, et al. Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst 1996; 88: 802.
27. De Villiers EM, Lavergne D,McLarenK,et al. Prevailing papillomavirus types in non-melanoma carcinomas of the skin in renal allograft recipients. Int J Cancer 1997; 73: 356.